These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models. Logsdon DP, Grimard M, Luo M, Shahda S, Jiang Y, Tong Y, Yu Z, Zyromski N, Schipani E, Carta F, Supuran CT, Korc M, Ivan M, Kelley MR, Fishel ML. Mol Cancer Ther; 2016 Nov; 15(11):2722-2732. PubMed ID: 27535970 [Abstract] [Full Text] [Related]
4. Blocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survival. Logsdon DP, Shah F, Carta F, Supuran CT, Kamocka M, Jacobsen MH, Sandusky GE, Kelley MR, Fishel ML. Sci Rep; 2018 Sep 13; 8(1):13759. PubMed ID: 30214007 [Abstract] [Full Text] [Related]
5. Prognostic role and correlation of CA9, CD31, CD68 and CD20 with the desmoplastic stroma in pancreatic ductal adenocarcinoma. Diana A, Wang LM, D'Costa Z, Azad A, Silva MA, Soonawalla Z, Allen P, Liu S, McKenna WG, Muschel RJ, Fokas E. Oncotarget; 2016 Nov 08; 7(45):72819-72832. PubMed ID: 27637082 [Abstract] [Full Text] [Related]
6. Clinical impact of carbonic anhydrase 9 expression on neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinoma. Terai T, Nishiwada S, Nagai M, Nakamura K, Kohara Y, Yasuda S, Matsuo Y, Doi S, Sakata T, Kumada H, Watanabe M, Sho M. Pancreatology; 2024 Sep 08; 24(6):938-946. PubMed ID: 39152081 [Abstract] [Full Text] [Related]
7. Prognostic significance and immune infiltration of microenvironment-related signatures in pancreatic cancer. Lu Q, Zhang Y, Chen X, Gu W, Ji X, Chen Z. Medicine (Baltimore); 2021 Mar 26; 100(12):e24957. PubMed ID: 33761652 [Abstract] [Full Text] [Related]
9. Genetic disruption of the pHi-regulating proteins Na+/H+ exchanger 1 (SLC9A1) and carbonic anhydrase 9 severely reduces growth of colon cancer cells. Parks SK, Cormerais Y, Durivault J, Pouyssegur J. Oncotarget; 2017 Feb 07; 8(6):10225-10237. PubMed ID: 28055960 [Abstract] [Full Text] [Related]
10. Activation of carbonic anhydrase IX by alternatively spliced tissue factor under late-stage tumor conditions. Ramchandani D, Unruh D, Lewis CS, Bogdanov VY, Weber GF. Lab Invest; 2016 Dec 07; 96(12):1234-1245. PubMed ID: 27721473 [Abstract] [Full Text] [Related]
11. Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma. Said HM, Hagemann C, Carta F, Katzer A, Polat B, Staab A, Scozzafava A, Anacker J, Vince GH, Flentje M, Supuran CT. Bioorg Med Chem; 2013 Jul 01; 21(13):3949-57. PubMed ID: 23706268 [Abstract] [Full Text] [Related]
12. Bioinformatics analyses of infiltrating immune cell participation on pancreatic ductal adenocarcinoma progression and in vivo experiment of the therapeutic effect of Shuangshen granules. Hu J, Jiang J, Xu B, Li Y, Wang B, He S, Ren X, Shi B, Zhang X, Zheng H, Hua B, Liu R. J Ethnopharmacol; 2024 Mar 25; 322():117590. PubMed ID: 38113986 [Abstract] [Full Text] [Related]
13. Carbonic anhydrase 9 confers resistance to ferroptosis/apoptosis in malignant mesothelioma under hypoxia. Li Z, Jiang L, Chew SH, Hirayama T, Sekido Y, Toyokuni S. Redox Biol; 2019 Sep 25; 26():101297. PubMed ID: 31442913 [Abstract] [Full Text] [Related]
14. Establishment of a Prognostic Model for Pancreatic Cancer Based on Hypoxia-Related Genes. Wu Y, Zhou J, Kou Q, Sun L, Ma Y, Yang T, Hu X. Technol Cancer Res Treat; 2024 Sep 25; 23():15330338241288687. PubMed ID: 39431298 [Abstract] [Full Text] [Related]
15. Evaluation of carbonic anhydrase IX as a potential therapeutic target in urothelial carcinoma. Todenhöfer T, Gibb EA, Seiler R, Kamyabi A, Hennenlotter J, McDonald P, Moskalev I, Stewart C, Gao J, Fazli L, Dedhar S, Stenzl A, Oo HZ, Black PC. Urol Oncol; 2021 Aug 25; 39(8):498.e1-498.e11. PubMed ID: 34083096 [Abstract] [Full Text] [Related]
16. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential. Knudsen ES, Balaji U, Freinkman E, McCue P, Witkiewicz AK. Oncotarget; 2016 Nov 29; 7(48):78396-78411. PubMed ID: 27623078 [Abstract] [Full Text] [Related]
17. Crucial role of carbonic anhydrase IX in tumorigenicity of xenotransplanted adult T-cell leukemia-derived cells. Nasu K, Yamaguchi K, Takanashi T, Tamai K, Sato I, Ine S, Sasaki O, Satoh K, Tanaka N, Tanaka Y, Fukushima T, Harigae H, Sugamura K. Cancer Sci; 2017 Mar 29; 108(3):435-443. PubMed ID: 28075522 [Abstract] [Full Text] [Related]
18. Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma. Tang R, Liu X, Liang C, Hua J, Xu J, Wang W, Meng Q, Liu J, Zhang B, Yu X, Shi S. Front Immunol; 2021 Mar 29; 12():648917. PubMed ID: 33777046 [Abstract] [Full Text] [Related]
19. Cellular and radiobiological effects of carbonic anhydrase IX in human breast cancer cells. Güttler A, Theuerkorn K, Riemann A, Wichmann H, Kessler J, Thews O, Bache M, Vordermark D. Oncol Rep; 2019 Apr 29; 41(4):2585-2594. PubMed ID: 30720123 [Abstract] [Full Text] [Related]
20. Investigation of the Prognostic Role of Carbonic Anhydrase 9 (CAIX) of the Cellular mRNA/Protein Level or Soluble CAIX Protein in Patients with Oral Squamous Cell Carcinoma. Eckert AW, Horter S, Bethmann D, Kotrba J, Kaune T, Rot S, Bache M, Bilkenroth U, Reich W, Greither T, Wickenhauser C, Vordermark D, Taubert H, Kappler M. Int J Mol Sci; 2019 Jan 16; 20(2):. PubMed ID: 30654595 [Abstract] [Full Text] [Related] Page: [Next] [New Search]